Programme 2025

British Summer Time (BST)

Day 1: Thursday 13:00 - 17:30

13:00 - 13:10

Welcome and Introduction

Giuseppe Luigi Banna (UK) & Ravindran Kanesvaran (Singapore)

Prostate (1h)

Chair: Ravindran Kanesvaran (Singapore) Discussant: Elena Castro (Spain)

13:10 - 13:30

Toward precision oncology

Neeraj Agarwal (USA)

13:30 - 13:50

Theragnostic revolution

Partha S. Choudhury (India)

13:50 - 14:10

Translating trial endpoints into clinically meaningful decisions

Alison Tree (UK)

14:10 - 14:50

Industry Symposia 4th September - View List

Symposia are organised and fully funded by pharma companies. Click "View list" for further info.

14:50 - 15:20

Coffee Break (30')

Rare & GU other matters (1h 10')

Chair: Giuseppe L. Banna (UK) Discussant: Simon Crabb (UK)

15:20 - 15:40

Minimising toxicity in testicular cancer

Pasquale Rescigno (UK)

15:40 - 16:10

Treatment breaks in GU Cancer: Is it safe?

Renal

Sara Elena Rebuzzi (Italy)

Bladder

Simon Crabb (UK)

16:10 - 16:30

MDTs: Gold Standard or Bottleneck in Urological Cancer Care?

Ben Lamb (UK)

Poster Awards (30')

Chair: Ravindran Kanesvaran (Singapore) Discussant: Matteo Santoni (Italy)

16:30 - 16:45

Poster Award

16:45 - 17:00

Selected poster discussion

Aruni Ghose (UK)

17:00 - 17:30

ePoster sessions (30')

Day 2: Friday 09:00 - 13:00

09:00 - 09:10

Introduction

Bladder (1h)

Chair: Ravindran Kanesvaran (Singapore) Discussant: Param Mariappan (UK)

09:10 - 09:30

How perioperative treatment is evolving

Petros Grivas (USA)

09:30 - 09:50

Getting more patients to the right 1st line of treatment

Enrique Grande (Spain)

09:50 - 10:10

Histology subtypes in bladder cancer; have they been left behind

Stefanie Zschäbitz (Germany)

10:10 - 10:50

Industry Symposia 5th September - View List